Prednisone Completed Phase 2 Trials for Castration Resistant Prostate Cancer (CRPC) Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT01120470OGX-427 in Castration Resistant Prostate Cancer Patients